Related Experiment Video
Updated: May 15, 2026

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Insulin analog with additional disulfide bond has increased stability and preserved activity
Tine N Vinther1, Mathias Norrman, Ulla Ribel
1Diabetes Research Unit, Novo Nordisk A/S, Novo Nordisk Park, Måløv DK-2760, Denmark.
Researchers engineered a novel insulin analog with an extra disulfide bond, enhancing its stability and potency. This breakthrough improves insulin's pharmaceutical potential by increasing its resistance to degradation and fibril formation.
Area of Science:
- Biochemistry
- Endocrinology
- Protein Engineering
Background:
- Insulin is crucial for glucose homeostasis, with a conserved structure featuring three disulfide bonds essential for function.
- Enhanced structural stability is desirable for pharmaceutical insulin applications.
Purpose of the Study:
- To investigate if an additional disulfide bond can improve insulin's structural stability and pharmaceutical properties.
- To design and characterize a novel insulin analog with a fourth disulfide bond.
Main Methods:
- Designed an insulin analog with an additional interchain disulfide bond at positions A10/B4.
- Assessed insulin receptor binding affinity and glucodynamic potency in a rat model.
- Determined melting temperature, evaluated fibril formation under stress, and analyzed crystal structure.
Main Results:
- The novel analog exhibited increased insulin receptor affinity and augmented glucodynamic potency.
- A 34.6°C increase in melting temperature and prevention of insulin fibril formation were observed.
- The analog retained hexamer formation capability and showed minor structural deviations from human insulin.
Conclusions:
- The first insulin analog with a fourth disulfide bond demonstrates enhanced structural stability and retained function.
- This engineered insulin shows promise for pharmaceutical development due to improved stability and potency.
- The study suggests the R-state conformation is not essential for insulin receptor binding.
Related Concept Videos
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Oral Hypoglycemic Agents: Glinides
Dipeptidyl Peptidase 4 Inhibitors
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

